Abstract

Metabolic diseases such as obesity, type II diabetes and hepatic steatosis are a public health concern in developed countries. The metabolic risk is gender‐dependent. The constitutive androstane receptor (CAR), which is at the crossroads between energy metabolism and endocrinology, has recently emerged as a promising therapeutic agent for the treatment of obesity and type 2 diabetes. In this study we sought to determine its role in the dimorphic regulation of energy homeostasis. We tracked male and female WT and CAR deficient (CAR−/−) mice for over a year. During aging, CAR−/− male mice developed hypercortisism, obesity, glucose intolerance, insulin insensitivity, dyslipidemia and hepatic steatosis. Remarkably, the latter modifications were absent, or minor, in female CAR−/− mice. When ovariectomized, CAR−/− female mice developed identical patterns of metabolic disorders as observed in male mice. These results highlight the importance of steroid hormones in the regulation of energy metabolism by CAR. They unveil a sexually dimorphic role of CAR in the maintenance of endocrine and metabolic homeostasis underscoring the importance of considering sex in treatment of metabolic diseases.

Details

Title
Dimorphic metabolic and endocrine disorders in mice lacking the constitutive androstane receptor
Author
Lukowicz Céline 1 ; Ellero-Simatos Sandrine 1 ; Régnier Marion 1 ; Oliviero Fabiana 1 ; Lasserre Frédéric 1 ; Polizzi Arnaud 1 ; Montagner, Alexandra 1 ; Sarra, Smati 1 ; Boudou Frédéric 2 ; Lenfant Françoise 2 ; Guzylack-Pirou Laurence 1 ; Menard Sandrine 1   VIAFID ORCID Logo  ; Barretto, Sharon 1 ; Fougerat Anne 1 ; Lippi Yannick 1   VIAFID ORCID Logo  ; Naylies Claire 1 ; Bertrand-Michel, Justine 3 ; Belgnaoui, Afifa Ait 1 ; Theodorou Vassilia 1 ; Marchi, Nicola 4 ; Gourdy Pierre 2 ; Gamet-Payrastre Laurence 1 ; Loiseau, Nicolas 1   VIAFID ORCID Logo  ; Guillou Hervé 1 ; Mselli-Lakhal Laïla 1 

 Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France (GRID:grid.420267.5) 
 I2MC, Institut National de la Santé et de la Recherche Médicale (INSERM)-U 1048, Université de Toulouse 3 and CHU de Toulouse, Toulouse, France (GRID:grid.462178.e) (ISNI:0000 0004 0537 1089) 
 Metatoul-Lipidomic Facility, MetaboHUB, Institut National de la Santé et de la Recherche Médicale (INSERM), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France (GRID:grid.457379.b) 
 Laboratory of Cerebrovascular and Glia Research, Department of Neuroscience, Institute of Functional Genomics (UMR 5203 CNRS – U 1191 INSERM, University of Montpellier), Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2330969149
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.